Phase 2 Clinical Trial of Simultaneous Boost Intensity Modulated Radiation Therapy With 3 Dose Gradients in Patients With Stage I-II Nasal Type Natural Killer/T-Cell Lymphoma: Long-Term Outcomes of Survival and Quality of Life

Authors:

Abstract
No abstract available
Funding Information
  • Natural Science Foundation of Guangdong Province (2023A1515011600)
  • Guangdong Medical Research Foundation (A2022121)

This publication has 42 references indexed in Scilit: